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resulting from metabolic changes (Abrahamse et 
al., 1999), caused by environmental toxins or drug 
administration (Abd-Allah et al., 1999; Puhakka et 
al., 2002) and some nutritional deficiencies (Gio-
vannelli et al., 2002; Szete et al., 2002; White et al., 
2002; Kapiszewska et al., 2005a). It was shown that 
the comet assay used to study single/double strand 
breaks and oxidative modifications in the DNA bas-
es was sensitive enough to detect also alterations in 
the antioxidant status in the body induced by nu-
tritional supplements or vitamins (Betancourt et al., 
1995; Anderson et al., 1997; Anderson, 2001; Beani, 
2001). The endogenous DNA damage analyzed in 
lymphocytes is very oen used as a biomarker of 
the oxidative stress in the human body (Porrini et 
al., 2002; Szeto et al., 2002; Wolf et al., 2002; Mayne, 
2003). Constant exposure of lymphocytes to sub-
stances transported by circulation make them very 
useful and reliable as a diagnostic tool. Taking all 
of the above into account, it is reasonable to expect 
that if circulating estrogens and their metabolites 
enhance free radical production, then their detri-
mental effect can be manifested in DNA modifica-
tion also in lymphocytes. We showed recently that 
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The risk of hormone-related cancer, in par-
ticular breast cancer, seems to depend on the pro-
longed exposure to 17β-estradiol and its hydroxy-
lated metabolites, i.e. catechol estrogens, which are 
easily auto-oxidized to semiquinones and subse-
quently to quinones (Huang et al., 1999; Thompson 
& Ambrosone, 2000). Since both compounds are 
electrophiles, they can covalently bind to nucle-
ophilic groups in DNA, forming stable and unsta-
ble DNA adducts (Peluso et al., 2000; Raogianis 
et al., 2000). Moreover, the redox cycling reaction 
between semiquinones and O-quinone radicals gen-
erate superoxide and hydroxyl radicals which can 
cause oxidative cleavage of the phosphate-sugar 
backbone, as well as oxidation of purine/pyrimi-
dine residues of DNA (Liehr, 1997; 2000). The ex-
tent of this damage is evaluated mainly by HPLC 
or by comet assay (Singh et al., 1988; Olinski et al., 
1998; Tice et al., 2000; Collins et al., 2002). The single 
strand breaks in DNA and alkali-labile sites (ALS), 
such as apurynic/apyrimidinic sites, can be detected 
as the proportion of DNA in the comet tail during 
alkaline microgel electrophoresis. This method has 
been widely used to study the DNA modifications 
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the protective ability of plant extracts against oxida-
tive DNA damage induced by hydrogen peroxide in 
lymphocytes depends on the concentration of 17β-es-
tradiol circulating in the blood and on the catechol-
O-methyltransferase (COMT) phenotype (Kapisze-
wska et al., 2005). The COMT enzyme is involved in 
detoxification through methylation of catechol estro-
gens inhibiting the redox cycling, thereby decreas-
ing reactive oxygen species formation (Matsui et al., 
2000). The enzyme activity is determined, in part, by 
a common genetic polymorphism. The COMT en-
zyme activity is 3–4-fold lower in the variant with a 
single nucleotide mutation (L*), causing a Val108Met 
substitution, as compared to the homozygous wild-
type (H/H) (Lavigne et al., 1997). Such a correlation 
between the COMT genotype and the activity of the 
enzyme was found in different human tissues (Lev-
i et al., 1982; Casey & MacDonald, 1983; Nissinen, 
1985; Nissinen et al., 1988; Li et al., 1989; Matsui et 
al., 2000). The availability of methyl group donors, 
which in turn indirectly depends on the folate and 
vitamin B12 status in the body, also influences the 
efficiency of the detoxification (Fenech, 2001; Good-
man et al., 2001; Kapiszewska et al., 2005). 
The results presented here verify our earlier 
observation that endogenous alkali-labile DNA dam-
age is strictly related to 17β-estradiol concentration 
in the follicular phase (FPh), and that lymphocyte 
DNA susceptibility is associated with the COMT 
genotype.
MATERIALS AND METHODS
Chemicals. Agarose for electrophoresis, 
grade ultra pure, and agarose normal and low melt-
ing point ultra pure, medium (RPMI 1640), serum 
(FBS), phosphate-buffered saline (PBS) and antibiot-
ics were purchased from Gibco BRL (UK); Agarose 
Top Vision, dNTPs and Pfu DNA polymerase were 
from Fermentas (Lithuania), while NlaIII restriction 
enzyme was from Q-Biogen; DMSO (dimethyl sul-
foxide), ethidium bromide, propidium iodide, Tris 
were from Sigma (USA); DNA Extraction Kit was 
from A&A (Poland); EDTA, Triton X100 was sup-
plied by MP Biomedicals; oligonucleotide primers 
were synthesized by Institute of Biochemistry and 
Biophysics, PAS (Warsaw, Poland); salts and hy-
droxides were from POCh (Poland).
Study design. The female volunteers com-
posed a very homogeneous group in terms of age, 
weight, lifestyle and smoking habits. They had not 
taken oral contraceptives or other hormonal medica-
tions for six months before the study began. They 
were not taking any other medications and had no 
history of recent infections. Samples were collected 
from subjects during a single normal menstrual cy-
cle at two specific time points: in the early follicular 
phase (days 1–3 post-onset of menses) and during 
the late follicular phase (days 13–15 post-onset of 
menses), designated in the text, Figures and Tables 
as EFPh and LFPh, respectively. The study protocol 
was reviewed and approved by the Ethics Commit-
tee of the Jagiellonian University Medical College. 
Sample preparation and analysis. The con-
centrations of 17β-estradiol and folate in plasma 
were determined by radioimmunoassay using com-
mercially available kits manufactured by Orion (Fin-
land) at the Department of Clinical Biochemistry, 
Jagiellonian University Hospital (Krakow, Poland). 
Peripheral blood lymphocytes. Peripheral 
blood lymphocytes were isolated using the Histo-
paque technique according to the manufacturer’s 
instructions (Sigma) and were frozen at –80oC at 4 
× 106 cells/ml in “freezing medium” consisting of 
65% RPMI-1640, 25% fetal bovine serum and 10% 
DMSO. 
Comet assay. The single cell gel electrophore-
sis (comet assay) procedure was described in details 
in our previous study (Kapiszewska et al., 2005a). 
Briefly, the lymphocytes were embedded in 0.5% low 
melting point agarose (LMPA) and spread on micro-
scopic slides pre-coated with 100 μl of 0.5% normal 
melting point agarose. The slides were immersed in 
cold lysing solution (2.5 M NaCl, 100 mM EDTA, 10 
mM Tris, pH 10, 10% DMSO, and 1% Triton X-100) 
for 1 h and washed with Tris buffer. For visualiza-
tion of DNA damage, observations were made using 
a 10× objective (the final magnification was × 200) 
on an epifluorescence microscope (Olympus IX-50) 
equipped with appropriate filters. The microscope 
was linked to a computer through a CCD camera 
(i.CAM-hrM; sensor SONY ICX). The Comet Plus 
image analysis system from Theta System Gmbh 
(Germany) was used for the quantification of DNA 
damage. 
The percentage of DNA in the tail (designated 
in the Figures as TDC) was automatically calculated. 
At least two slides per one subject, with 50 random-
ly selected cells per slide, were analyzed. 
COMT genotype analysis. The COMT geno-
type was determined by polymerase chain reaction-
restriction fragment length polymorphism (PCR-
RFLP) using the NlaIII restriction enzyme. Details of 
the method are described elsewhere (Kapiszewska et 
al., 2005). 
Statistical analyses. Data obtained from the 
comet assay (% tail DNA, “TDC”) were subjected to 
a logarithmic transformation because of heterogene-
ity of variance. The correlation between DNA dam-
age and 17β-estradiol concentration in the plasma 
was examined with the linear regression analysis us-
ing the least-squares method. The results were pre-
sented as a scaer plot with a linear regression line 
fied to the data with a 95% confidence interval. A 
correlation coefficient (r) and P values were calcu-
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lated. The association between the COMT polymor-
phism and the ALS, calculated using mean values 
from measurements taken in EFPh and LFPh, was 
analyzed by non-parametric Mann-Whitney U-test 
and presented as a Box Whisker plot. 
RESULTS AND DISCUSSION
The comet assay is mainly used to evaluate 
genotoxic hazard of drugs, chemicals or environ-
mental exposure. Its sensitivity, however, allows 
evaluation also of DNA modification due to less 
severe agents, such as physical exercise, diabetes 
or different UV exposure and nutrition in various 
seasons (Hartmann et al., 1994; Sardas et al., 2001; 
Dusinska et al., 2002). This means that an enhance-
ment in the DNA comet migration can also be ob-
served as a result of physiological processes and not 
only due to genotoxic exposure. These breaks cannot 
be distinguished from those which reflect the geno-
toxic effect. Moreover, they may represent the tran-
sient error-free repair sites. 
Using the alkaline version of comet assay 
we assessed whether the variation in the circulat-
ing level of 17β-estradiol in the follicular phase of 
menstrual cycle can affect the extent of endogenous 
DNA damage in lymphocytes isolated from healthy 
women donors.
As data obtained in human studies can be 
biased by confounding factors, the donors (n = 16) 
were chosen for our study in such a way as to create 
a very homogeneous group in terms of age (32 years 
± 3), weight (61.4 kg ± 9.6), life-style and smoking 
habits (non-smokers). The concentrations of 17β-es-
tradiol and folate in the plasma were analyzed by 
radioimmunoassay. The mean values are shown in 
Table 1. The mean values of 17β-estradiol concentra-
tion in the plasma in EFPh and LFPh were signifi-
cantly different (P = 0.001). The differences in folate 
concentrations in EFPh and LFPh were not statisti-
cally significant. 
The analyzed level of ALS was significantly 
positively correlated with the estradiol concentration 
only in LFPh, where the concentration of 17β-estra-
diol was in the range from 36 to 368 pg/ml (r = 0.53; 
P = 0.03) (Fig. 1). No such dependence was observed 
in EFPh, where mean 17β-estradiol concentration 
was 30.8 pg/ml (Table 1). The extent of ALS was not 
correlated with the averaged EFPh + LFPh concen-
tration of 17β-estradiol in the plasma calculated for 
each individual (P = 0.09).
 There is a background level of DNA dam-
age in normally functioning cells due to metabolic 
activities, including reactive oxygen species (ROS) 
production. This damage is not detrimental until an 
imbalance between the pro-oxidant and anti-oxidant 
factors occurs. DNA strand breaks can be caused di-
rectly by the aack of hydroxyl radicals formed dur-
ing the oxidation of catechol estrogens. Thus, if more 
catechol estrogens are produced in the late follicular 
phase, as compared to the early phase, more alkali-
labile sites in DNA can be induced. This hypothesis 
was confirmed by our results. 
In individuals with more efficient detoxifica-
tion/methylation of catechol estrogens less damage 
can be expected, as the methylation not only pre-
vents the redox cycling between semiquinones and 
quinines, which decreases ROS production, but also 
forms methyl ether metabolites with a strong anti-
oxidant activity.
More ALS was found in FPh in lymphocytes 
isolated from blood of women with the COMT L/L 
genotype, as compared to the heterozygous variant 
(H/L) and wild-type genotype (H/H) grouped to-
gether (P = 0.05) (Fig. 2). The mean values of 17β-
estradiol concentration in both groups were similar, 
that is the difference between them was statistically 
insignificant  (P = 0.8). Since the folate concentration 
in plasma in both groups was not significantly differ-
ent (9.7 ng/ml ± 1.04 and 10.9 ng/ml ± 4.9 for COMT 
L/L and COMT (H/L + H/H), respectively), the find-
ing implicates that more DNA damage in the COMT 
L/L group can result from insufficient detoxification 
of catechol estrogens due to lower COMT L/L activ-
Table 1. Mean values of 17β-estradiol and folate concen-
tration in plasma during a single menstrual cycle in ear-
ly and late follicular phases (days 1–3 or 13–15 post-onset 
menses, respectively).
Early folli-
cular phase
(EFPh)
Late follicu-
lar phase
(LFPh)
P-value
17β-Estradiol 
(pg/ml) 30.8 ± 25.5 154.8 ± 105.0 0.001
Folate (ng/ml) 9.6 ± 6.2 11.6 ± 5.7 0.3
Figure 1. Correlation between 17β-estradiol concentra-
tion in plasma during the late follicular phase (LFPh) in 
lymphocytes isolated from blood and alkali-labile DNA 
damage.
The DNA damage was analyzed by comet assay and ex-
pressed as the percentage of DNA in the tail (TDC). The 
correlation (r = 0.53 and P = 0.03) was evaluated by linear 
regression analysis using the least-squares method.
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ity. Since the number of subjects in the L/L group 
(n = 3) was much lower than in the group with the 
combined genotypes (n = 13), the conclusion has to 
be drawn carefully until the results are confirmed 
with more subjects. 
The observed variation in endogenous DNA 
lesions during the follicular cycle indicates that eval-
uation of genotoxicity of drugs and environmental 
toxins should also take into account the influence 
of physiological processes which take place in the 
studied subjects during the investigation. For exam-
ple, the activity of the immune system can also be 
responsible for a correlation between 17β-estradiol 
concentration and DNA lesions. It has been postu-
lated that estrogen in the follicular phase contributes 
to the development of an immune response classi-
fied as Th1, which is characterized by the produc-
tion of cytokines, such as IFN-γ, IL-2, and TNF-β. 
Furthermore, concentration of TNF-α fluctuates over 
the menstrual cycle and significantly increases dur-
ing the late follicular phase (Brannstrom et al., 1999). 
These inflammatory mediators are generated de-
pending on estrogen concentration, leading to DNA 
damage, including strand breakage (Cutolo et al., 
2002; 2004; Lang, 2004; Rosales et al., 2004; Salem, 
2004). Also, at the time of ovulation, the number of 
neutrophils increases 8-fold; that may influence local 
production of cytokines, including IL-1, TNF-α and 
IL-8 (Brannstrom et al., 1993). Thus, endogenous oxi-
dative DNA damage in lymphocytes from the late 
follicular phase, as compared with the early phase, 
may not necessarily only reflect the harmful effect 
of 17β-estradiol and its metabolites but can be also a 
sign of the activation of Th1 cells. 
CONCLUSION
Association between endogenous DNA dam-
age in lymphocytes and 17β-estradiol concentration 
in circulation can partially explain the inter-individ-
ual variation of the extent of endogenous DNA dam-
age in lymphocytes from healthy donors, as report-
ed in many studies (Buschfort et al., 1997; Martin et 
al., 2000; Gonzalez et al., 2002). Also, involvement of 
polymorphism of genes responsible for the detoxify-
ing pathways in the induction of endogenous DNA 
damage should not be ignored.
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